Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_992_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Contents
- •Contributors
- •Series Editors' preface
- •Editors' preface
- •Acknowledgements
- •Chronic liver failure
- •Metabolic liver function
- •Measuring liver volume
- •Blood tests of liver function
- •Tests of liver function measuring substance clearance
- •Indocyanine green (ICG)
- •Hepatobiliary scintigraphy
- •Lidocaine (MEG-X)
- •Aminopyrine breath test
- •Urea synthesis
- •Glutathione synthesis
- •Measuring liver blood flow
- •Effect of major liver resection on hepatic blood flow
- •Effect of major liver resection on innate immunity
- •Liver regeneration
- •Molecular signals for hepatic regeneration
- •Cell populations involved in liver regeneration
- •Evidence-based practice in surgery
- •Overview of liver functions and evolution
- •Symptoms of liver failure: acute and chronic
- •Common causes of acute liver failure: hepatic insufficiency following liver resections
- •Consequences of surgery
- •Small-for-size syndrome
- •Hepatic steatosis
- •Assessment of steatosis
- •Chemotherapy-induced liver changes
- •Portal vein embolisation
- •Technique
- •Therapy for liver failure
- •N -Acetyl cysteine
- •Nutritional support in liver failure
- •Artificial extracorporeal liver support
- •Artificial liver support
- •Bioartificial liver systems
- •Liver transplantation
- •Cell therapy for liver failure: general principles
- •Haemopoetic stem cell therapy for liver disease in humans
- •Future developments
- •References
- •Liver
- •Overview of hepatic anatomy and terminology
- •Divisions of the liver based on the hepatic artery
- •Resectional terminology
- •Surgical anatomy for liver resections
- •Hepatic arteries and liver resections
- •Bile ducts and liver resections
- •Prevailing pattern and important variations of bile ducts draining the right hemiliver
- •Prevailing pattern and important variations of bile ducts draining the left hemiliver
- •Prevailing pattern of bile ducts draining the caudate lobe (Sg1)
- •Portal veins and liver resections
- •Ramification of the left portal vein (Figs 2.10 and 2.11)
- •Hepatic veins and liver resection (Fig. 2.13)
- •The plate/sheath system of the liver
- •Liver capsule and attachments
- •Surface anatomy
- •Gallbladder and extrahepatic bile ducts
- •Gallbladder
- •Agenesis of the gallbladder
- •Double gallbladder
- •Cystic duct
- •Cystic artery
- •Extrahepatic bile ducts
- •Anomalies of extrahepatic bile ducts
- •Extrahepatic arteries
- •Blood supply of bile ducts
- •Pancreas
- •Pancreatic ducts
- •Blood supply of the pancreas
- •Lymphatics of the pancreas
- •References
- •Introduction
- •Colorectal liver metastases
- •Transabdominal ultrasound
- •Computed tomography and magnetic resonance imaging
- •Positron emission tomography
- •Diagnostic laparoscopy and laparoscopic ultrasound
- •Staging and assesment of resectability
- •Hepatocellular carcinoma
- •Transabdominal ultrasound
- •Computed tomography and magnetic resonance imaging
- •Diagnostic laparoscopy and laparoscopic ultrasound
- •Staging and assesment of resectability
- •Pancreatic and periampullary carcinoma
- •Transabdominal ultrasound
- •Computed tomography and magnetic resonance imaging
- •Endoscopic retrograde cholangiopancreatography (ERCP)
- •Endoscopic ultrasound
- •Positron emission tomography
- •Diagnostic laparoscopy and laparoscopic ultrasound
- •Staging and assesment of resectability
- •Positron emission tomography
- •Diagnostic laparoscopy and laparoscopic ultrasound
- •Staging and assesment of resectability
- •References
- •Introduction
- •Proximal bile duct tumours
- •Transabdominal ultrasound
- •Computed tomography and magnetic resonance imaging
- •Endoscopic retrograde cholangiopancreatography
- •Classification
- •Haemangiomas
- •Pathology
- •Clinical presentation
- •Management
- •Liver cell adenoma
- •Pathology
- •Clinical presentation
- •Management
- •Focal nodular hyperplasia
- •Pathology
- •Clinical features
- •Management
- •Nodular regenerative hyperplasia (macroregenerative nodules)
- •Bile duct adenoma (bile duct hamartoma)
- •Hepatic pseudotumours
- •Miscellaneous benign tumours
- •Liver abscess
- •Clinical presentation
- •Management
- •Amoebic abscess
- •Hydatid cyst
- •Clinical presentation
- •Management
- •Simple cysts of the liver
- •Clinical presentation
- •Management
- •Polycystic liver disease (PCLD)
- •Clinical presentation
- •Management
- •Cystadenoma
- •References
- •Introduction
- •Hepatocellular carcinoma
- •Incidence of HCC
- •Risk factors for HCC
- •Cirrhosis
- •HBV infection
- •HCV infection
- •Human immunodeficiency virus (HIV) infection
- •Other viral infections
- •Alcohol
- •Non-alcoholic fatty liver disease (NAFLD)
- •Hereditary haemochromatosis
- •Cirrhosis of other aetiologies
- •Aflatoxin
- •Metabolic liver diseases
- •Adenoma, contraceptives and androgens
- •Pathology of HCC and nodular lesions in chronic liver disease
- •Clinical presentation
- •Liver function tests and tumour markers
- •Liver function tests
- •Serum tumour markers
- •α-Fetoprotein
- •Others serum tumour markers
- •Radiological studies
- •Ultrasound
- •Computed tomography
- •Magnetic resonance imaging
- •Contrast-enhanced ultrasound
- •Other imaging
- •Angiography
- •Positron emission tomography
- •Accuracy of imaging techniques
- •Requirement for and reliability of histological assessment
- •Diagnosis of HCC
- •Natural history of HCC and staging systems
- •Screening for HCC
- •Treatment options
- •HCC in normal livers
- •Liver resection of HCC in cirrhotic patients
- •Liver resection
- •Main limitations
- •Risk of surgery and patient selection
- •Technique
- •Outcome after resection
- •Treatment of recurrence
- •Liver transplantation (LT)
- •Rationale
- •Patient selection
- •Treatment on the waiting list
- •Transarterial chemoembolisation (TACE)
- •Technique
- •Contraindications
- •Morbidity and mortality
- •Monitoring
- •Efficacy
- •Percutaneous local ablative therapy
- •Technique
- •Advantages and drawbacks
- •Contraindications and limitations
- •Methods and margins
- •Indication
- •Other palliative treatments
- •Conventional systemic chemotherapy
- •Anti-angiogenic targeted therapies
- •Radioembolisation
- •Other treatments
- •Defining a treatment strategy
- •Uncomplicated HCC associated with chronic liver disease
- •Treatment of complicated HCC
- •HCC with macroscopic portal vein invasion
- •HCC with macroscopic invasion of hepatic veins
- •Ruptured HCC
- •Fibrolamellar carcinoma (FLC)
- •Intrahepatic cholangiocarcinoma (ICCA)
- •Incidence
- •Risk factors
- •Classification and staging
- •Pathology and progression analysis
- •Clinical presentation and laboratory tests
- •Imaging studies
- •Diagnosis
- •Treatment
- •Angiosarcoma
- •Primary hepatic lymphoma
- •References
- •Introduction
- •Preoperative staging: the key to selection of candidates for curative treatment
- •Computed tomography (CT)
- •Magnetic resonance imaging (MRI)
- •Positron emission tomography (PET)
- •Staging laparoscopy
- •Cardiopulmonary exercise testing
- •Surgery: the old and the new standards for resection
- •Criteria for resection
- •Surgical strategies to improve resectability
- •Portal vein embolisation
- •Two-stage hepatectomy
- •Repeat hepatectomy
- •Extreme liver surgery
- •Extrahepatic colorectal disease
- •Techniques of surgical resection
- •Transection techniques
- •Fibrin sealants
- •Laparoscopic liver surgery: less is more?
- •Morbidity, mortality and survival after liver resection for CRLMs
- •Classification of CRLMs
- •Staging systems and terminology
- •Chemotherapy for CRLMs
- •Agents
- •Clarifying the intent of chemotherapy in CRLMs
- •Conversion/induction chemotherapy
- •Perioperative chemotherapy
- •Pathological response to chemotherapy as a predictor of long-term outcome
- •Chemotherapy-associated hepatotoxicity
- •Liver-targeted therapies
- •Hepatic arterial infusion
- •Drug-eluting beads for TACE (DEB-TACE)
- •Selective internal radiation treatment (SIRT)
- •Ablative therapies for CRLMs
- •Radiofrequency ablation
- •Microwave ablation
- •Multidisciplinary team approach
- •Conclusions
- •References
- •Introduction
- •Pathophysiology and molecular basis of liver metastases
- •Treatment strategies
- •Neuroendocrine tumours
- •Gastrointestinal stromal tumours
- •Breast cancer
- •Ovarian cancer
- •Renal cell carcinoma
- •Melanoma
- •Non-colorectal gastrointestinal adenocarcinoma
- •Testicular cancer
- •Urothelial cancer
- •Lung cancer
- •Adrenocortical tumours
- •Endometrial cancer
- •Conclusion
- •References
- •Introduction
- •Aetiology and pathophysiology of portal hypertension
- •The natural history of portal hypertension
- •Presentation
- •Imaging
- •Management of varices
- •Therapeutic aims for pharmacological therapy in portal hypertension
- •Oesophageal varices
- •Primary prophylaxis for the prevention of variceal haemorrhage
- •Prevention of re-bleeding from oesophageal varices (secondary prophylaxis)
- •Treatment for bleeding oesophageal varices
- •Gastric varices
- •Portal hypertensive gastropathy
- •Second-line therapies
- •TIPS (transjugular intrahepatic portosystemic shunt)
- •TIPS for variceal bleeding
- •Surgical options
- •Portal systemic shunts
- •Liver transplantation
- •Selection of second-line therapy
- •Non-cirrhotic
- •Cirrhotic
- •Management of ascites
- •Budd–Chiari syndrome
- •Acute Budd–Chiari syndrome
- •Chronic Budd–Chiari syndrome
- •Non-cirrhotic portal hypertension
- •Portal vein thrombosis
- •Segmental portal hypertension
- •TIPS and portal vein thrombosis
- •References
- •Introduction
- •Postsplenectomy sepsis
- •Trauma
- •Elective indications for splenectomy
- •Immune thrombocytopenic purpura
- •Evans syndrome
- •Hereditary spherocytosis
- •Elliptocytosis
- •Thallassaemias
- •Sickle cell anaemia
- •Autoimmune haemolytic anaemia
- •Lymphoma
- •Myeloid disease
- •Volvulus
- •Haemangiomas
- •Cysts
- •Portal hypertension
- •Preparation for splenectomy
- •Technique
- •Open splenectomy
- •Laparoscopic splenectomy
- •Postoperative management and complications
- •Summary
- •References
- •Introduction
- •Composition, formation and risk factors
- •Presentation
- •Cholecystolithiasis
- •Pathophysiology
- •Clinical features
- •Choledocholithiasis
- •Pathophysiology
- •Clinical features
- •Investigation
- •Blood tests
- •Ultrasonography
- •Endoscopic ultrasound (EUS)
- •Computed tomography (CT)
- •Radioisotope scanning
- •Magnetic resonance cholangiopancreatography (MRCP)
- •Percutaneous transhepatic cholangiography (PTC)
- •Endoscopic retrograde cholangiopancreatography (ERCP)
- •Management of gallbladder stones
- •Asymptomatic stones
- •Non-operative treatments for gallstones
- •Dissolution
- •Lithotripsy
- •Operative treatment of gallbladder stones
- •Open cholecystectomy
- •Mini-laparotomy cholecystectomy
- •Laparoscopic cholecystectomy
- •Symptomatic gallstones
- •Acute cholecystitis
- •Complications
- •Day-case laparoscopic cholecystectomy
- •Needlescopic cholecystectomy
- •Bile duct injury
- •Cholecystostomy
- •Subtotal cholecystectomy
- •Intraoperative cholangiography (IOC)
- •Routine IOC
- •Selective IOC
- •Bile duct injury
- •Laparoscopic ultrasound (LUS)
- •Management of common bile duct stones
- •Laparoscopic transcystic common bile duct exploration
- •Laparoscopic choledochotomy
- •Open choledochotomy
- •Endoscopic retrograde cholangiopancreatography (ERCP)
- •ERCP stent insertion
- •Preoperative ERCP
- •Intraoperative ERCP
- •Postoperative ERCP
- •Laparoscopic exploration of the CBD versus preoperative or postoperative ERCP
- •Recurrent or retained CBD stones
- •Transhepatic stone retrieval
- •Acalculous biliary pain
- •References
- •Introduction
- •Congenital anomalies
- •Biliary atresia
- •Choledochal cysts
- •Classification
- •Risk of malignancy
- •Management
- •Special operative techniques
- •Iatrogenic biliary injury
- •Aetiology
- •Techniques to avoid injury
- •Classification
- •Presentation
- •Management
- •Intraoperative recognition
- •Postoperative recognition: biliary fistula
- •Postoperative recognition: biliary obstruction
- •The timing of repair
- •Early repair
- •Delayed repair
- •Associated vascular injury
- •Further imaging
- •Operative techniques
- •Management of complications related to repair
- •Revisional surgery
- •Liver resection and transplantation
- •Prognosis
- •Success of repair
- •Survival
- •Quality of life
- •Associated malignancy
- •Benign biliary strictures
- •Mirizzi's syndrome
- •Presentation
- •Management
- •Hepatolithiasis
- •Management
- •Parasitic infestation causing jaundice
- •Liver flukes (trematodes)
- •Echinococcus
- •Treatment
- •Ascaris lumbricoides
- •Primary sclerosing cholangitis
- •Aetiology
- •Presentation
- •Investigation
- •Management
- •Exclusion of associated malignant stricture
- •Biliary strictures imitating malignancy
- •Lymphoplasmacytic sclerosing pancreatitis
- •Functional biliary disorders
- •References
- •Introduction
- •Cholangiocarcinoma
- •General considerations
- •Epidemiology
- •Natural history
- •Aetiology
- •Histopathology
- •Cholangiocarcinoma involving the proximal bile ducts (hilar cholangiocarcinoma)
- •Clinical presentation and diagnosis
- •Radiological investigation
- •Direct cholangiography
- •Computed tomography
- •Duplex ultrasonography
- •Magnetic resonance cholangiopancreatography (MRCP)
- •Preoperative evaluation and assessment of resectability
- •Treatment options
- •Resection
- •Results of resection
- •Adjuvant therapy
- •Palliation
- •Percutaneous biliary drainage
- •Intrahepatic biliary-enteric bypass
- •Radiation therapy
- •Photodynamic therapy
- •Chemotherapy
- •Cholangiocarcinoma involving the distal bile duct
- •Clinical presentation and diagnosis
- •Staging and assessment of resectability
- •Treatment options
- •Cholangiocarcinoma involving the intrahepatic bile ducts
- •Clinical presentation
- •Diagnosis
- •Radiological investigations
- •Staging and assessment of resectability
- •Treatment options
- •Gallbladder cancer
- •Epidemiology/aetiology
- •Clinical presentation and diagnosis
- •Histopathology and staging
- •Evidence for an aggressive surgical approach
- •Surgical therapy
- •T1 tumours
- •T2 tumours
- •T3 tumours
- •T4 tumours
- •Preoperative suspicion of malignancy
- •Unsuspected malignancy at exploration
- •Malignancy diagnosed post-cholecystectomy
- •Adjuvant therapy
- •Palliation
- •References
- •General description
- •Pathophysiology
- •Natural history
- •Diagnosis
- •Aetiology
- •Obstructive factors
- •Biliary disease
- •Benign pancreatic duct stricture
- •Tumours of the ampulla or pancreas
- •Toxic factors
- •Metabolic factors
- •Genetic defects
- •Trauma
- •Iatrogenic causes
- •Inflammatory
- •Physiological
- •Sphincter manometric abnormalities
- •Assessment of severity
- •Single biochemical measures
- •C-reactive protein (CRP)
- •Other single predictive markers
- •Intra-abdominal hypertension (IAH)
- •Repeated clinical assessment
- •Imaging
- •Role of ultrasound (US)
- •Role of CT
- •Role of magnetic resonance (MR)/magnetic resonance cholangiopancreatography (MRCP)
- •Endoscopic ultrasound (EUS)
- •Management
- •Initial management
- •Supportive management
- •Specific medical management
- •Prevention of infection
- •Nutritional support
- •Nutritional delivery in the patient with acute pancreatitis
- •Disease modulation through content or mode of delivery
- •Other medical therapies
- •Inhibition of pancreatic secretion
- •Inhibition of pancreatic enzymes
- •Inhibition of the inflammatory response
- •Role of ERCP
- •Definitive management issues
- •Prevention of recurrent acute pancreatitis
- •Management of gallstones
- •Investigation of non-gallstone-associated pancreatitis
- •Peripancreatic fluid collections
- •Management of an early fluid collection
- •Management of a pseudocyst
- •Percutaneous drainage
- •Endoscopic drainage
- •Surgical drainage of an acute post-inflammatory collection
- •Management of a pancreatic duct fistula
- •Management of necrosis
- •Management of sterile necrosis
- •Management of infected necrosis (early phase, 2–6 weeks)
- •Methods of necrosectomy
- •Open laparotomy/debridement
- •Minimally invasive approaches to infected necrosis
- •Management of pancreatic abscess
- •Specific late complications
- •Haemorrhage
- •Segmental portal hypertension and gastrointestinal haemorrhage
- •Pancreatic duct stricture
- •Gastric outlet obstruction
- •References
- •Summary
- •Definition
- •Incidence
- •Aetiology
- •Clinical course
- •Pathophysiological findings and pain mechanisms in chronic pancreatitis
- •Calcifying CP
- •Autoimmune pancreatitis
- •Hereditary CP
- •Pathogenesis of pain in chronic pancreatitis
- •Preoperative assessment and investigations
- •Laboratory evaluation
- •Imaging studies
- •Treatment
- •Conservative therapy
- •Endoscopic and interventional treatment
- •Endoscopy
- •Surgical therapy, timing and indications
- •Surgical techniques
- •Selection of the surgical intervention
- •Pancreatico-duodenectomy
- •Distal and total pancreatectomy
- •Partington–Rochelle procedure
- •Longitudinal pancreatico-jejunostomy and cyst drainage
- •Beger procedure
- •Frey procedure
- •Berne procedure
- •Hamburg procedure
- •V-shaped excision
- •Selection of the procedure
- •Salvage procedures
- •Complications of chronic pancreatitis
- •References
- •Introduction
- •Epidemiology
- •Risk factors (see Box 15.1)
- •Smoking
- •Diet and alcohol
- •Occupation
- •Past medical history
- •Hereditary pancreatic cancer
- •Precursor lesions
- •Presentation
- •Investigation
- •Serology
- •Markers
- •Diagnosis
- •Imaging studies
- •Cytology/histology
- •Advanced staging techniques
- •Laparoscopy
- •Pathology
- •Treatment
- •Resection
- •Pancreatico-duodenectomy
- •Extended lymph node and vascular dissection
- •Distal pancreatectomy
- •Laparoscopic pancreatectomy
- •Total pancreatectomy
- •Central pancreatectomy
- •Surgical palliation
- •Obstructive jaundice
- •Upper GI tract outflow obstruction
- •Adjuvant therapies
- •Neoadjuvant therapy
- •Future areas of interest
- •References
- •Introduction
- •Intraductal papillary mucinous neoplasms
- •Clinical presentation
- •Investigation
- •Pathology
- •Management
- •Outcome
- •Pancreatic neuroendocrine tumours
- •Clinical presentation
- •Investigations
- •Biochemical
- •Radiology
- •Treatment
- •Metastatic disease
- •Pathology and outcome
- •Other tumours
- •References
- •Introduction
- •Liver trauma
- •Mechanisms of liver injury
- •Classification of liver injury
- •Diagnosis of liver injury
- •Other diagnostic/therapeutic modalities for the assessment and treatment of liver injury
- •Management of liver injury: selection of patients for non-operative management
- •Operative management of liver injury
- •General strategy
- •Choice of incision
- •Intraoperative assessment
- •Perihepatic packing
- •Techniques for surgical haemostasis
- •Resectional debridement
- •Anatomical liver resection
- •Selective ligation of the hepatic artery
- •Management of hepatic venous and retrohepatic caval injury
- •Ex vivo surgery and liver transplantation
- •Complications of liver trauma
- •Complications of non-operative management
- •Postoperative complications after surgery for liver trauma
- •Outcome after liver injury
- •Extrahepatic biliary tract trauma
- •Incidence of biliary injury
- •Classification of biliary injury
- •Presentation and diagnosis of biliary injury
- •Operative management of biliary injury
- •Outcome after biliary injury
- •Pancreatic trauma
- •Mechanisms of pancreatic injury
- •Diagnosis of pancreatic injury
- •Classification of pancreatic injury
- •Initial management of pancreatic injury
- •Operative management of pancreatic injury
- •Complications of pancreatic injury
- •Conclusion
- •References
- •Index

Chapter 10
especially at the ampulla. This requires skills using
the lithoclast for certain circumstances and laser or
electrohydrolic fragmentation for others. Expertise
in this area renders the transduodenal sphincteroplasty approach obsolete.
For those embarking on laparoscopic exploration,
careful consideration of the strategies to be employed, equipment required and adequacy of assistance will go a long way to simplifying a potentially
complex procedure. When laparoscopic transcystic
exploration fails, the surgeon has three options:
• toligatethecysticduct,completethe
cholecystectomy and rely on postoperative ERCP;
• toperformalaparoscopiccholedochotomy;
• toperformalaparotomyandopenexplorationof
the CBD.
If laparoscopic choledochotomy fails, the options
include: insertion of a T-tube and subsequent extraction of the retained stones via the T-tube track after
6 weeks; postoperative ERCP and sphincterotomy;
or conversion to open exploration CBD. Individual
circumstances will dictate which option is the most
suitable, although this should be discussed carefully
with the patient before a management strategy is
implemented.
It has been suggested that preoperative ERCP is
the most cost-effective management of patients at
high risk for CBD stones.
106
There is evidence accumulating, however, that where transcystic clearance is successful this leads to less morbidity and
more rapid recovery.
83,88
The author believes the
most cost-effective approach is laparoscopic cholecystectomy, IOC and transcystic clearance of
CBD stones, reserving ERCP for retained stones.
Learning the techniques to achieve this seems
worthwhile.
In a recent extensive review of the literature, it
was concluded that laparoscopic CBD exploration
is safe and effective for all patients presenting with
gallstones and may be a better way of removing
CBD stones than ERCP.
107,108
Recurrent or retained CBD stones
Recurrent CBD stones occur in up to 10% of
cases. In a retrospective series of 169 patients
followed for up to 19 years, recurrences were
more common in patients with primary duct
stones, large CBD diameter (around 16 mm) and
periampullary diverticula. Lowest recurrence
rates were found in those patients undergoing
choledochoduodenostomy.
Retained CBD stones found at postoperative
T-tube cholangiography are best dealt with by
ERCP. If ERCP is unsuccessful or not available,
73
exploration of the CBD via the T-tube tract is indicated. It usually takes approximately 6 weeks
for the T-tube track to mature, at which time
percutaneous choledochoscopy or radiologically
guided extraction can be performed. A cholangiogram is obtained immediately prior to the procedure as a proportion of stones will have passed
spontaneously.
The T-tube is removed, a guidewire is left in situ,
and either a steerable catheter or choledochoscope
is advanced down the track and into the CBD. With
choledochoscopy, the remainder of the technique is
identical to that carried out at open operation.
109
With the steerable catheter technique, fluoroscopy
and further cholangiograms are taken as the stones
are retrieved with a stone basket.
110
If there is uncertainty as to the completeness of
clearance, a straight tube may be inserted to keep
the track open for a further attempt a few days
later. Both techniques are successful in more than
95% of cases and carry less risk of complications
such as pancreatitis or haemorrhage than ERCP.
Providing there are no time constraints and the patient is happy to be managed as an outpatient with
a T-tube, the technique is effective.
Transcystic exploration of the common bile
duct at the time of cholecystectomy is an effective
means of managing choledocholithiasis with low
morbidity and cost.
ERCP is effective in managing the remaining
patients in whom this is not achievable and is the
accepted means of managing the patient presenting
with acute cholangitis.
Transhepatic stone retrieval
In a few patients, particularly those who have previously undergone a Pólya gastrectomy, the ampulla
will not be readily accessible for ERCP. Access to
the common duct can be achieved using a percutaneous transhepatic technique. Over a percutaneously inserted guidewire, a series of dilators are
advanced into the biliary tree, so as to develop a
transhepatic tract. Following insertion of a sheath,
a choledochoscope or steerable catheter can be inserted and stones retrieved.
111
Acalculous biliary pain
Given the poor understanding of the mechanisms
of pain production in patients with acalculous
biliary disease, the outcome for patients following
cholecystectomy is uncertain. There is gathering
evidence that some patients have abnormal motility
190

Gallstones
Cholelithiasis
Failure
of the sphincter of Oddi, in addition to the gallbladder. Some authors have reported improvement in
symptoms in as many as 85–95% of patients with
acalculous biliary pain after cholecystectomy,
but it is conceivable that surgery confers a placebo
effect. Controversy exists over the use of cholecystokinin (CCK) provocation tests as a means of reproducing symptoms and predicting which patients
might benefit from cholecystectomy. In one study,
all 26 patients with positive CCK tests showed
improvement after removal of the gallbladder,
whereas 10 of the 16 patients with negative tests
were found to have other pathology accounting for
their pain. Despite these encouraging results, other
investigators have failed to demonstrate differences
112
in outcome in patients with positive CCK tests
when compared to those with negative tests.
Objective criteria on which to base the decision to
recommend cholecystectomy in such patients are
difficult to define. It is clear, however, that despite
the minimally invasive nature of laparoscopic cholecystectomy, there should be no relaxation in the
113
indications for cholecystectomy in patients with
acalculous biliary pain.
Key points
• Asymptomatic gallstones do not require surgical intervention.
• The standard treatment for symptomatic gallstones is now laparoscopic, and there are few
exceptions to a trial of a laparoscopic approach in all comers.
• All surgeons undertaking cholecystectomy, by whatever technique, should be capable of
performing operative cholangiography.
• The use of operative cholangiography appears to be associated with a lower incidence of bile duct
injury.
• Experience is accumulating that transcystic clearance of the CBD at the time of cholecystectomy
is effective, with low morbidity and cost. In the one-third of patients where this is not achievable,
ERCP is probably the best means of clearance.
• An algorithm for the management of common bile duct stones is shown in Fig. 10.9. The
management strategy chosen will depend on personal experience, equipment availability, time and
the availability of other departmental expertise. There is no consensus as to the ideal approach.
114
Suspicion of CBD stones
Routine per-op cholangiogram
CBD stones
Open
exploration
CBD
Failure
Figure10.9 • Algorithm showing the available strategies for management of common bile duct stones.
Laparoscopic
cholecystectomy
Post-op
ERCP
Laparoscopic
exploration
CBD
Failure
Selective per-op cholangiogram
Laparascopic cholecystectomy
No stones
Pre-op ERCP
CBD stones
Endoscopic sphincterotomy
and duct clearance
Success
Open
exploration
CBD
Failure
Laparoscopic
exploration
CBD
191

Chapter 10
References
1. Godfrey PJ, Bates T, Harrison M, et al. Gallstones
and mortality: a study of all gallstone related
deaths in a single health district. Gut 1984;25:
1029–33.
2. Hospital In-patient Inquiry Main tables Department
of Health and Social Security/Office of Population
Census and Surveys. London: HMSO; 19801989.
3. American College of Surgeons. Socio-economic fact
book for surgery. Chicago: Socioeconomic Affairs
Department, American College of Surgeons; 1988.
4. Motson RW. Operative cholangiography. In:
Motson RW, editor. Retained common duct stones.
Prevention and treatment. London: Grune &
Stratton; 1985. p. 8–9.
5. Neoptolemos JP, Hofmann AF, Moossa AR.
Chemical treatment of stones in the biliary tree. Br
J Surg 1986;73:515–24.
6. Bennion LJ, Grundy SM. Risk factors for the development of cholelithiasis in man. N Engl J Med
1978;299:1161–221.
7. Scragg RK, McMichael AJ, Seamark RF. Oral contraceptives, pregnancy and endogenous oestrogen
in gallstone disease – a case controlled study. Br
Med J (Clin Res Ed) 1984;288:1795–9.
8. Scragg RK, McMichael AJ, Paghurst PA. Diet,
alcohol and relative weight in gallstone disease:
a case controlled study. Br Med J (Clin Res Ed)
1984;288:1113–8.
9. Richardson WS, Surowiec WJ, Carter KM, et al.
Gallstone disease in heart transplant recipients.
Ann Surg 2003;237:273–6.
10. Festi D, Colecchia A, Orsini M, et al. Gallbladder
motility and gallstone formation in obese patients
following very low calorie diets. Int J Obes Relat
Metab Disord 1998;22(6):592–600.
11. Nakeeb A, Comuzzie AG, Martin L, et al.
Gallstones: genetics versus environment. Ann Surg
2002;235(6):842–9.
12. Dowling RH, Veysey MJ, Pereira SP, et al. Role of
intestinal transit in the pathogenesis of gallbladder
stones. Can J Gastroenterol 1997;11(1):57–64.
13. Vitek L, Carey MC. New pathophysiologic concepts underlying pathogenesis of pigment gallstones. Clin Res Hepatol Gastroenterol 2012;36(2):
122–9.
14. Keighley MRB. Micro-organisms in the bile. A preventable cause of sepsis after biliary surgery. Ann R
Coll Surg Engl 1977;59:328–34.
15. Glenn F, Moody FG. Acute obstructive suppurative
cholangitis. Surg Gynecol Obstet 1961;113:
265–73.
16. Taylor TV, Torrance B, Rimmer S, et al. Operative
cholangiography: is there a statistical alternative?
Am J Surg 1983;145:640–3.
17. Wilson TG, Hall JC, Watts JM. Is operative
cholangiography always necessary? Br J Surg
1986;73:637–40.
18. Prat F, Meduri B, Ducot B, et al. Prediction of common bile duct stones by noninvasive tests. Ann
Surg 1999;229(3):362–8.
19. Lindsel DRM. Ultrasound imaging of pancreas and
biliary tract. Lancet 1990;335:390–3.
20. Prat F, Amouyal G, Amouyal P, et al. Prospective
controlled study of endoscopic ultrasonography
and endoscopic retrograde cholangiography in patients with suspected common bile duct lithiasis.
Lancet 1996;347(8994):75–9.
A study making the case for endoscopic ultrasonography as an alternative to ERCP for the detection of
common bile duct stones.
21. Norton SA, Alderson D. Endoscopic ultrasonography in the evaluation of idiopathic acute pancreatitis. Br J Surg 2000;87:1650–5.
22. Baroll RL. Common bile duct stones. Reassessment
of criteria for CT diagnosis. Radiology 1987;162:
419–24.
23. Ichii H, Takada M, Kashiwagi R, et al. Threedimensional reconstruction of biliary tract using
spiral computed tomography for laparoscopic cholecystectomy. World J Surg 2002;26:608–11.
24. Hochwalk SN, Dobransky M, Rofsky NM, et al.
Magnetic resonance cholangiopancreatography accurately predicts the presence or absence of choledocholithiasis. J Gastrointest Surg 1998;2(6):573–9.
25. Masui T, Takehara Y, Fujiwara T, et al. MR and CT
cholangiography in evaluation of the biliary tract.
Acta Radiol 1998;39(5):557–63.
26. Liu TH, Consorti ET, Kawashima A, et al. Patient
evaluation and management with selective use
of magnetic resonance cholangiography and endoscopic retrograde cholangiopancreatography
before laparoscopic cholecystectomy. Ann Surg
2001;234(1):33–40.
27. Gracie WA, Ransahoff DF. The natural history of
silent gallstones: the innocent gallstone is not a
myth. N Engl J Med 1982;307:798–800.
28. McSherry CK, Glenn F. The incidence and causes of
death following surgery for non-malignant biliary
tract disease. Ann Surg 1980;191:271–5.
29. Lagergren J, Mattsson F. Cholecystectomy as a risk
factor for oesophageal adenocarcinoma. Br J Surg
2011;98:1133–7.
30. Schmidt M, Søndenaa K, Vetrhus M, et al. A randomized controlled study of uncomplicated gallstone disease with 14-year follow-up showed that
operation was the preferred treatment. Dig Surg
2011;28:270–6.
31. Iser JH, Dowling RH, Mok HYI, et al.
Chenodeoxycholic acid treatment of gallstones.
N Engl J Med 1975;293:333–78.
192

Gallstones
32. O'Donnell LDJ, Heaton KW. Recurrence and rerecurrence of gallstones after medical dissolution:
a long-term follow-up. Gut 1988;29:655–8.
33. Ahmed R, Freeman JV, Ross B, et al. Long term
response to gallstone treatment – problems and
surprises. Eur J Surg 2000;166:447–54.
34. Sauerbruch T, Stern M. Fragmentation of bile duct
stones by extracorporeal shockwaves. A new approach to biliary calculi after failure of routine endoscopic measures. Gastroenterology 1989;96:146–52.
35. Clavien PA, Sanabria JR, Mentha G, et al. Recent
results of elective open cholecystectomy in a North
American and a European centre – comparison
of complications and risk factors. Ann Surg
1992;216:618–26.
36. Bredesen J, Jorgensen T, Andersen TF, et al. Early
postoperative mortality following cholecystectomy
in the entire female population of Denmark –
1977–1991. World J Surg 1992;16:530–5.
Both these papers document the results of open
cholecystectomy prior to the advent of laparoscopic
cholecystectomy.
37. Andren-Sandberg A, Alinder A, Bengmark S.
Accidental lesions of the common bile duct at cholecystectomy: pre- and peroperative factors of importance. Ann Surg 1985;201:328–33.
Frequently cited study that documents risk factors implicated in injury to the common bile duct during open
cholecystectomy.
38. Connor S, Garden OJ. Bile duct injury in the
era of laparoscopic cholecystectomy. Br J Surg
2006;93:158–68.
39. Bates T, Ebbs SR, Harrison M, et al. Influence
of cholecystectomy on symptoms. Br J Surg
1991;78:964–7.
40. MacMahon AJ, Russell IT, Baxter JN, et al.
Laparoscopic versus minilaparotomy cholecystectomy: a randomised trial. Lancet 1994;343:135–8.
41. Majeed AW, Troy G, Nicholl JP, et al. Randomised,
prospective, single-blind comparison of laparoscopic versus small-incision cholecystectomy.
Lancet 1996;347:989–94.
42. Ros A, Gustafsson L, Krook H, et al. Laparoscopic
cholecystectomy versus mini-laparotomy cholecystectomy: a prospective, randomised, single-blind
study. Ann Surg 2001;234(6):741–9.
No evidence to support routine mini-cholecystectomy.
43. Dubois F, Icard P, Berthelot G, et al. Coelioscopic
cholecystectomy. Ann Surg 1990;211:60–2.
44. Nathanson LK, Shimi S, Cuschieri A. Laparoscopic
cholecystectomy: the Dundee technique. Br J Surg
1991;78:155–9.
45. Gramatica L, Brasesco OE, Mercado LA, et al.
Laparoscopic cholecystectomy performed under regional anaesthesia in patients with chronic
obstructive pulmonary disease. Surg Endosc
2002;16:472–5.
46. Ghumman E, Barry M, Grace PA. Management of
gallstones in pregnancy. Br J Surg 1997;84:1646–50.
47. Yeh CN, Chen MF, Jan YY. Laparoscopic cholecystectomy in 226 cirrhotic patients. Experience
of a single centre in Taiwan. Surg Endosc
2002;16:1583–7.
48. Cuschieri A, Dubois F, Mouiel J, et al. The
European experience of laparoscopic cholecystectomy. Am J Surg 1991;161:385–7.
49. The Southern Surgeons Club. A prospective analysis of 1518 laparoscopic cholecystectomies. N Engl
J Med 1991;324:1073–8.
50. Wilson P, Leese T, Morgan WP, et al. Elective laparoscopic cholecystectomy for ‘all comers’. Lancet
1991;338:795–7.
51. Unger SW, Rosenbaum G, Unger HM, et al.
A comparison of laparoscopic and open treatment
of acute cholecystitis. Surg Endosc 1993;7:408–11.
52. Navez B, Mutter D, Russier Y, et al. Safety of
laparoscopic approach for acute cholecystitis:
retrospective study of 609 cases. World J Surg
2001;25(10):1352–6.
53. Richards C, Edwards J, Culver D, et al. Does using
a laparoscopic approach to cholecystectomy decrease the risk of surgical site infection? Ann Surg
2003;3:358–62.
54. Al-Ghnaniem R, Benjamin IS, Patel AG. Metaanalysis suggests antibiotic prophylaxis is not
warranted in low-risk patients undergoing laparoscopic cholecystectomy. Br J Surg 2003;90:365–6.
55. Lau H, Brooks DC. Contemporary outcomes of ambulatory laparoscopic cholecystectomy in a major
teaching hospital. World J Surg 2002;26:1117–21.
56. Cheah WK, Lenzi JE, So BY, et al. Randomised
trial of needlescopic versus laparoscopic cholecystectomy. Br J Surg 2001;88:45–7.
57. Lai ECH, Yang GPC, Tang CN, et al. Prospective
randomized comparative study of single incision
laparoscopic cholecystectomy versus conventional
four-port laparoscopic cholestectomy. Am J Surg
2011;202:254–8.
58. Richardson MC, Bell G, Fullarton GM, The West
of Scotland Laparoscopic Cholecystectomy Audit
Group. Incidence and nature of bile duct injuries
following laparoscopic cholecystectomy: an audit
of 5913 cases. Br J Surg 1996;83:1356–60.
59. MacFadyen BV, Vecchio R, Ricardo AE, et al. Bile
duct injury after laparoscopic cholecystectomy.
Surg Endosc 1998;12:315–21.
60. Archer SB, Brown DW, Hunter JG, et al. Bile duct
injury during laparoscopic cholecystectomy: results
of a national survey. Ann Surg 2001;234(4):549–59.
61. Way LW, Stewart L, Hunter JG, et al. Causes
and prevention of laparoscopic bile duct injuries. Analysis of 252 cases from a human factors
and cognitive psychology perspective. Ann Surg
2003;4:460–9.
193

Chapter 10
62. Keus F, de Jong JAF, Gooszen HG, et al.
Laparoscopic versus open cholecystectomy for
patients with symptomatic cholecystolithiasis.
Cochrane Database Syst Rev 2006;(4):CD006231.
63. Fletcher DR, Hobbs M, Tan P, et al. Complications
of cholecystectomy. Risks of the laparoscopic approach and protective effects of operative cholangiography: a population-based study. Ann Surg
1999;229(4):449–57.
64. Flum DR, Dellinger EP, Cheadle A, et al.
Intraoperative cholangiography and risk of common bile duct injury during cholecystectomy.
JAMA 2003;289:1639–44.
Large study on 1.5 million patients demonstrating an
increased risk of common bile duct injury when intraoperative cholangiography was not used during laparoscopic cholecystectomy.
65. Snow LL. Evaluation of operative cholangiography
in 2043 patients undergoing laparoscopic cholecystectomy. A case for the selective operative cholangiogram. Surg Endosc 2001;15:14–20.
66. John TG, Banting SW, Pye S, et al. Preliminary
experience with intracorporeal laparoscopic
ultrasonography using a sector scanning probe.
A prospective comparison with intraoperative
cholangiography in the detection of choledocholithiasis. Surg Endosc 1994;8:1176–81.
67. Greig JD, John TG, Mahadaven M, et al.
Laparoscopic ultrasonography in the evaluation
of the biliary tree during laparoscopic cholecystectomy. Br J Surg 1994;84:1202–6.
68. Tranter SE, Thompson MH. Potential of laparoscopic ultrasonography as an alternative to operative cholangiography in the detection of bile duct
stones. Br J Surg 2001;88:65–9.
69. Tranter SE, Thompson MH. A prospective singleblinded controlled study comparing laparoscopic
ultrasound of the common bile duct with operative
cholangiography. Surg Endosc 2003;17:216–9.
70. Catheline JM, Turner R, Paries J. Laparoscopic ultrasonography is a complement to cholangiography
for the detection of choledocholithiasis at laparoscopic cholecystectomy. Br J Surg 2002;89:1235–9.
71. Tranter SE, Thompson MH. Spontaneous passage
of bile duct stones: frequency of occurrence and
relation to clinical presentation. Ann R Coll Surg
Engl 2003;85:174–7.
72. Lygidakis NJ. A prospective randomised study of
recurrent choledocholithiasis. Surg Gynecol Obstet
1982;155(5):679–84.
73. Panis Y, Fagniez PL, Brisset D, et al. Long-term
results of choledochoduodenostomy versus choledochojejunostomy for choledocholithiasis. Surg
Gynecol Obstet 1993;177(1):33–7.
Two studies stressing the need to consider a surgical
drainage procedure if ductal stones are thought to represent primary calculi.
74. Uchiyama K, Onishi H, Tani M, et al. Long-term
prognosis after treatment of patients with choledocholithiasis. Ann Surg 2003;238(1):97–102.
75. Jeyapalan M, Almeida JA, Michaelson RL, et al.
Laparoscopic choledochoduodenostomy: review of
a 4-year experience with an uncommon problem.
Surg Laparosc Endosc 2002;12(3):148–53.
76. Rhodes M, Nathanson L. Laparoscopic choledochoduodenostomy. Surg Laparosc Endosc
1996;6(4):318–21.
77. Strömberg C, Nilsson M. Nationwide study of the
treatment of common bile duct stones in Sweden between 1965 and 2009. Br J Surg 2011;98:1766–74.
78. Petelin JB. Clinical results of common bile
duct exploration. Endosc Surg Allied Technol
1993;1(3):125–9.
79. Berci G, Morgenstern L. Laparoscopic management of common bile duct stones. A multiinstitutional SAGES study. Society of American
Gastrointestinal Endoscopic Surgeons. Surg Endosc
1994;8:1168–74.
80. Rhodes M, Nathanson L, O'Rourke N, et al.
Laparoscopic exploration of the common bile duct:
lessons learned from 129 consecutive cases. Br J
Surg 1995;82:666–8.
81. Khoo D, Walsh CJ, Murphy C, et al. Laparoscopic
common bile duct exploration: evolution of a new
technique. Br J Surg 1996;83:341–6.
82. Martin IJ, Bailey IS, Rhodes M, et al. Towards
T-tube free laparoscopic bile duct exploration:
a methodologic evolution during 300 consecutive
procedures. Ann Surg 1998;228(1):29–34.
83. Cuschieri A, Lezoche E, Morino M, et al. E.A.E.S.
multicentre prospective randomised trial comparing two-stage vs. single-stage management of patients with gallstone disease and ductal calculi.
Surg Endosc 1999;13(10):952–7.
84. Rhodes M, Sussman L, Cohen L, et al. Randomised
trial of laparoscopic exploration of common bile
duct versus postoperative endoscopic retrograde
cholangiography for common bile duct stones.
Lancet 1998;351:159–61.
Two important randomised studies indicating success
of laparoscopic bile duct exploration.
85. Buddingh KT, Weersma RK, Savenije RAJ, et al.
Lower rate of major bile duct injury and increased intraoperative management of common
bile duct stones after implementation of routine
intraoperative cholangiography. J Am Coll Surg
2011;213:267–74.
86. Boerma D, Rauws EAJ, Keulemans YCA, et al.
Wait-and-see policy of laparoscopic cholecystectomy after endoscopic sphincterotomy for bile-duct
stones: a randomised trial. Lancet 2002;360:761–5.
87. Riciardi R, Islam S, Canete JJ, et al. Effectiveness
and long-term results of laparoscopic common bile
duct exploration. Surg Endosc 2003;17:19–22.
194

Gallstones
88. Nathanson LK, O'Rourke NA, Martin IJ, et al.
Postoperative ERCP versus laparoscopic choledochotomy for clearance of selected bile duct calculi:
a randomized trial. Ann Surg 2005;242(2):188–92.
89. Collins C, Maguire D, Ireland A, et al. A prospective study of common bile duct calculi in patients
undergoing laparoscopic cholecystectomy: natural
history of choledocholithiasis revisited. Ann Surg
2004;239(1):28–33.
90. Finnis D, Rowntree T. Choledochoscopy in exploration of the common bile duct. Br J Surg
1977;64:661–4.
91. Williams JA, Treacy PJ, Sidey P, et al. Primary duct
closure versus T-tube drainage following exploration of the common bile duct. Aust N Z J Surg
1994;64(12):823–6.
92. Tanaka M. Bile duct clearance, endoscopic or
laparoscopic? J Hepatobiliary Pancreat Surg
2002;9:729–32.
93. Leese T, Neoptolemos JP, Carr-Locke DL.
Successes, failures, early complications and their
management: results of 394 consecutive patients
from a single centre. Br J Surg 1985;72:215–9.
94. Ochi Y, Mukawa K, Kiyosawa K, et al. Comparing
the treatment outcomes of endoscopic papillary
dilation and endoscopic sphincterotomy for removal of bile duct stones. J Gastroenterol Hepatol
1999;14(1):90–6.
95. Vaira D, Ainley C, Williams S, et al. Endoscopic
sphincterotomy in 1000 consecutive patients.
Lancet 1989;ii:431–4.
Three reports supporting use of endoscopic removal of
common bile duct stones in high-risk surgical patients.
96. Lambert ME, Betts CD, Hill J, et al. Endoscopic
sphincterotomy – the whole truth. Br J Surg
1991;78:473–6.
97. Webber J, Ademak HE, Riemann JF. Extracorporeal
piezo-electric lithotripsy for retained bile duct
stones. Endoscopy 1992;24:239–43.
98. Shaw MJ, Mackie RD, Moore JP, et al. Results of
a multi-centre trial using a mechanical lithotriptor
for the treatment of large bile duct stones. Am J
Gastroenterol 1993;88:730–3.
99. Leese T, Neoptolemos JP, Baker AR, et al. Management
of acute cholangitis and the impact of endoscopic
sphincterotomy. Br J Surg 1986;73:988–92.
100. Leung JWC, Cotton PB. Endoscopic nasobiliary
catheter drainage in biliary and pancreatic disease.
Am J Gastroenterol 1991;86:389–94.
101. Neoptolemos JP, Carr-Locke DL, Fossard NP.
A prospective randomised study of pre- operative
endoscopic sphincterotomy versus surgery alone for
common bile duct stones. Br Med J 1987;294:470–4.
102. Barwood NT, Valinsky LJ, Hobbs M, et al.
Changing methods of imaging the common bile
duct in the laparoscopic cholecystectomy era in
Western Australia Implications for surgical practice. Ann Surg 2002;235(1):41–50.
103. Tatulli F, Cuttitta A. Laparoendoscopic approach
to treatment of common bile duct stones. J
Laparoendosc Adv Surg Tech 2000;10(6):315–7.
104. Ng T, Amaral J. Timing of endoscopic retrograde
cholangiopancreatography and laparoscopic
cholecystectomy in the treatment of choledocholithiasis. J Laparoendosc Adv Surg Tech Part A
1999;9(1):31–7.
105. Ammori BJ, Birbas K, Davides D, et al. Routine
vs ‘on demand’ postoperative ERCP for small bile
duct calculi detected at intraoperative cholangiography. Surg Endosc 2000;14:1123–6.
106. Urbach DR, Khanjanchee YS, Jobe BA, et al. Costeffective management of common bile duct stones.
Surg Endosc 2001;15:4–13.
107. Tranter SE, Thompson MH. Comparison of endoscopic sphincterotomy and laparoscopic exploration of the common bile duct. Br J Surg
2002;89:1495–504.
108. Martin DJ, Vernon DR, Toouli J. Surgical versus
endoscopic treatment of bile duct stones. Cochrane
Database Syst Rev 2006;(2): CD003327.
Similar clearance rates and more procedures with ERCP.
109. Menzies D, Motson RW. Percutaneous flexible
choledochoscopy: a simple method for retained
common bile duct stone removal. Br J Surg
1991;78(8):959–60.
110. Mason R. Percutaneous extraction of retained gallstones via the T-tube track – British experience of
131 cases. Clin Radiol 1980;31:587–97.
111. Nussinson E, Cairns SR, Vaira D, et al. A 10-year
single centre experience of percutaneous and endoscopic extraction of bile duct stones with T-tube in
situ. Gut 1991;32:1040–3.
112. Nathan MH, Newman MA, Murray DJ, et al.
Cholecystokinin cholecystography. Four years evaluation. AJR Am J Roentgenol 1970;110:240–51.
113. Lennard TWJ, Farndon JR, Taylor RMR.
Acalculous biliary pain: diagnosis and selection for
cholecystectomy using the cholecystokinin test for
pain reproduction. Br J Surg 1984;71:368–70.
114. Sunderland GT, Carter DC. Clinical application
of the cholecystokinin provocation test. Br J Surg
1988;75:444–9.
195

11
Benign biliary tract diseases
Benjamin N.J. Thomson
O.James Garden
Introduction
Apart from those disorders related to choledocholithiasis, benign diseases of the biliary tree are relatively uncommon (Box 11.1). The most challenging
issues are in patients who present with symptoms
associated with biliary strictures, which arise more
commonly following iatrogenic injury during cholecystectomy. Congenital abnormalities such as choledochal cysts and biliary atresia are usually in the
domain of the paediatric surgeon, although later presentation of cysts may occur after missed diagnosis
or when revisional surgery is required. Most of the
published literature regarding benign non- gallstone
biliary disease is retrospective or at best prospectively gathered, non-randomised data, but clear
guidelines can be followed based upon observation.
Congenital anomalies
Biliary atresia
Biliary atresia occurs in approximately 1 per 10 000
live births but its aetiology remains unclear. There is
experimental evidence for a primary perinatal infection as well as cellular and humoral autoimmunity.
An inflammatory process before birth may result in
failure of the biliary lumen to develop in all or part
of the extrahepatic biliary tree.
Presentation is usually in the early neonatal period with prolongation of neonatal jaundice. Most
patients are treated in specialist neonatal surgical
units; however, occasionally patients may be referred
to adult units for assessment for liver transplantation following previous unsuccessful treatment.
Management in the neonate is by porto-enterostomy
(Kasai's operation), which involves anastomosis
of a Roux limb of jejunum to the tissue of the hilum. Restoration of bile flow has been reported in
86% of infants treated before 8 weeks of age, but
only 36% in older children.1 Four-year survival is
dependent on the timing of surgery. Of 349 North
American children with biliary atresia, 210 (60%)
required later liver transplantation, with a 4-year
transplantation survival of 82%.2 Recent evidence
has suggested better outcomes following maternal
liver-related liver transplantation, potentially due to
tolerance to non-inherited maternal antigens.
3
Choledochal cysts
The earliest description of a choledochal cyst was by
Douglas in 1952,4 who described a 17-year-old girl
with jaundice, fever and a painful mass in the right
hypochondrium. However, presentation is usually
in childhood and around 25% are diagnosed in the
first year, although prenatal diagnosis is now possible with improvements in antenatal ultrasonography. Adult centres treat a small proportion of those
presenting with delayed diagnosis as well as those
with complications from previous cyst surgery.
The incidence of choledochal cysts in Western countries is around 1 in 200 000 live births but it is much
higher in Asia. There is frequent association with
other hepatobiliary disease such as hepatic fibrosis, as
well as an aberrant pancreatico-biliary duct junction.
5
196

Benign biliary tract diseases
Box11.1 • Benign causes of biliary strictures
Strictures of the extrahepatic biliary tree
Iatrogenic biliary injury
Postcholecystectomy
Trauma
Other
Gallstone related
Mirizzi's syndrome
Inflammatory
Recurrent pyogenic cholangitis
Parasitic infestation
Clonorchis sinensis
Opisthorchis viverrini
Echinococcus
Ascaris
Primary sclerosing cholangitis
Benign strictures imitating malignancy
Pancreatitis
Lymphoplasmacytic pancreatitis
Inflammatory pseudotumour
Idiopathic strictures
HIV cholangiopathy
Magnetic resonance cholangiopancreatography
(MRCP) now allows images that are superior to traditional cholangiography (Fig. 11.1), and it should
be recommended due to its non-invasive nature.
6
Classification
The modified Todani classification is employed to describe the various forms of choledochal cyst7 (Fig. 11.2).
Type I, the most common, represents a solitary cyst
characterised by fusiform dilatation of the common bile
duct. Type II comprises a diverticulum of the common
bile duct, whilst type III cysts are choledochocoeles.
Type IV is the second most common, with extension of
cysts into the intrahepatic ducts. Lastly, type V involves
intrahepatic cystic disease with no choledochal cyst,
which merges into the syndrome of Caroli's disease.
Risk of malignancy
In the Western literature, the incidence of cholangiocarcinoma is reported to be approximately
12% (Fig. 11.1),8 compared to Todani et al.'s
Japanese experience of 16% in 1353 patients.9 The
incidence of malignancy is reported to be 2% at
20 years, increasing to 43% for those in their sixties.10 Cyst drainage without cyst excision does not
prevent later malignant change, and there is continuing debate regarding the precise ongoing risk
following cyst resection. Takeshita et al. reported
180 patients who underwent primary surgery for
a choledochal cyst. Synchronous malignancy was
found in 36 patients (20%), with only one of the
remaining 144 patients developing malignancy
during follow-up.
11
Management
Surgical resection is required to prevent recurrent
episodes of sepsis and pain, to prevent the risk of
pancreatitis from passage of debris and calculi,
and because of the association with cholangiocarcinoma. Complete cyst excision with preservation
of the pancreatic duct is required, with hepaticojejunostomy for reconstruction. Some authors
advocate liver resection for type IV cysts with intrahepatic extension for complete removal of the
cyst, although the advantage is debatable. For those
patients with Caroli's disease, resection may be feasible if the biliary involvement is localised to one
part of the liver. For other patients, endoscopic or
radiological techniques may be required to address
biliary sepsis by improving biliary drainage, while
others may need to be considered for hepatic replacement if liver failure develops.
For extrahepatic cysts, cyst-enterostomy, or drainage of the cyst into the duodenum, should no longer
be performed as the cyst epithelium remains unstable
and malignant potential exists. If previous drainage
has been performed, symptoms of cholangitis generally persist and conversion to a Roux-en-Y hepaticojejunostomy is advisable.
a b
Figure11.1 • MRCP (a) and
macroscopic photograph
(b) demonstrating a type I choledochal
cyst with a distal cholangiocarcinoma
in a 42-year-old Caucasian woman
requiring a pancreaticoduodenectomy.
Gallbladder (GB), tumour (T), pancreatic
duct (single arrow) and aberrant
common channel (double arrow) are
shown. Courtesy of Professor Prithi
S. Bhathal, Pathology Department,
University of Melbourne, Australia.
197

Chapter 11
I II
III IVa
IVb V (Caroli's
Figure11.2 • Modified Todani classification for choledochal cysts.7 Reproduced from Todani T, Watanabe Y, Narusue
M et al. Congenital bile duct cysts: classification, operative procedures, and review of thirty-seven cases including cancer
arising from choledochal cyst. Am J Surg 1977; 134:263–9. With permission from Elsevier.
Special operative techniques
During operative exposure, intraoperative ultrasound is very useful to identify the biliary confluence, the intrahepatic extension of the cyst, and the
relationship to the right hepatic artery above and to
the pancreatic duct below (Fig. 11.3). Small aberrant
hepatic ducts may enter the cyst below the biliary
confluence and these are missed frequently on pre-
operative imaging.12 Such aberrant ducts are usually
identified once the cyst has been opened. The cyst is
disease)
198

Benign biliary tract diseases
common with the reduction in ulcer surgery and
increasing specialisation in pancreatico-biliary surgery. Rarely, the injury may be related to abdominal
trauma, injection of scolicidal agents in the management of hydatid cyst, ablation of hepatic tumours or
radiotherapy.
The true incidence of biliary injury following laparoscopic cholecystectomy remains obscure. It has
been suggested that there was a slight increase in
the incidence of injuries following initial introduction of the laparoscopic technique,13 with a reported
incidence of 0.3–0.7%.
said to have a lower incidence of biliary injury, with
a rate of 0.13%.17 Recent variations in technique
such as single-incision laparoscopic surgery (SILS)
cholecystectomy are not immune to biliary injury.
Han et al. recently reported two (1.5%) bile duct injuries in 150 patients having single-port laparoscopic
18
surgery.
14–16
Open cholecystectomy is
Figure11.3 • Operative ultrasound scan of a type I
choledochal cyst. The junction of the undilated proximal
biliary tree with the cyst (long dotted line) is demonstrated.
The right hepatic artery is posterior (two arrows), as is the
right branch of the portal vein (short dotted line).
normally best excised in its entirety and this is facilitated by opening it along its anterior length. This
aids identification of the vessels from which the cyst
is freed. Early identification of the biliary confluence aids the surgeon in planning the incorporation
of any segmental duct into the eventual hepaticojejunal Roux-en-Y anastomosis. Dissection into the
head of the pancreas is made easier by use of bipolar
scissors and the CUSA™ (ultrasonic surgical aspiration system, ValleyLab, Boulder, CO) if the plane of
dissection is obscured by fibrosis or inflammation.
It may be necessary to leave a small oversewn lower
common bile duct stump to avoid compromise to
the pancreatic duct lumen; however, recurrent pancreatitis and possible malignant transformation remain possible complications.
There is an accepted association between
choledochal cyst and cholangiocarcinoma. The cyst
should be excised and the biliary tree reconstructed
by means of a hepatico-jejunostomy Roux-en-Y.
Iatrogenic biliary injury
The commonest cause of an injury to the extrahepatic biliary tree is as a result of an iatrogenic injury at the time of cholecystectomy. Although it is
recognised that injury may also occur during other
gastric or pancreatic procedures, this is much less
Aetiology
Previous reports of injury during laparoscopic cholecystectomy suggested that injury was more likely
to occur when performed for pancreatitis, cholangitis or acute cholecystitis.19 However, in a prospective analysis of patients referred following biliary
injury, 71% occurred in patients in whom the indication for cholecystectomy was biliary colic alone,20
and thus surgeons should always be vigilant regardless of the indication.
In the majority of patients the problem is misinterpretation of the biliary anatomy, with the common bile duct being confused with the cystic duct.
Associated injury to the right hepatic artery often
occurs as it is mistaken for the cystic artery. Partial
injury may occur to the common bile duct after a
diathermy burn or due to rigorous traction on the
cystic duct, leading to its avulsion from the bile duct.
Techniques to avoid injury
Many techniques have been described to decrease
the risk of injury to the common bile duct during cholecystectomy. The main risk factors are
thought to be inexperience, aberrant anatomy and
inflammation.
laparoscopic bile duct injuries, the authors suggested that the primary cause of error was a visual
perceptual illusion in 97% of cases, whilst faults in
technical skill were thought to have been present in
only 3% of injuries.
Correct identification of the biliary anatomy is
essential in avoiding injury to the extrahepatic bile
duct. Dissection of Hartmann's pouch should start
at the junction of the gallbladder and cystic duct
and continue lateral to the cystic lymph node, thus
19,21
However, in an analysis of 252
22
199
Соседние файлы в папке Библиотека им академика М.И. Перельмана
